Short Interest in Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) Increases By 94.6%

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) was the target of a large growth in short interest during the month of June. As of June 30th, there was short interest totaling 4,249 shares, a growth of 94.6% from the June 15th total of 2,184 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average trading volume of 11,212 shares, the short-interest ratio is currently 0.4 days.

Aimei Health Technology Stock Down 1.3%

Shares of AFJK stock opened at $11.85 on Friday. Aimei Health Technology has a 52-week low of $6.75 and a 52-week high of $130.37. The stock has a market cap of $37.56 million, a PE ratio of 74.07 and a beta of 0.55. The business has a 50-day simple moving average of $32.38 and a 200-day simple moving average of $39.85.

Aimei Health Technology (NASDAQ:AFJK) last posted its earnings results on Tuesday, June 16th. The company reported $0.01 EPS for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of Aimei Health Technology in a report on Wednesday, June 24th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, Aimei Health Technology currently has an average rating of “Sell”.

Institutional Investors Weigh In On Aimei Health Technology

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Jane Street Group LLC purchased a new position in shares of Aimei Health Technology in the 4th quarter valued at about $302,000. Dakota Wealth Management acquired a new position in Aimei Health Technology in the 4th quarter worth about $406,000. Geode Capital Management LLC purchased a new position in Aimei Health Technology during the fourth quarter worth approximately $413,000. Quarry LP boosted its position in Aimei Health Technology by 6.4% during the third quarter. Quarry LP now owns 167,081 shares of the company’s stock worth $1,891,000 after purchasing an additional 10,000 shares in the last quarter. Finally, Clear Street Group Inc. grew its holdings in Aimei Health Technology by 36.5% in the fourth quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock valued at $5,334,000 after purchasing an additional 22,294 shares during the period. Institutional investors and hedge funds own 45.58% of the company’s stock.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.